Evonik is expanding its RESOMER portfolio of bioresorbable polymers for controlled-release parenteral drug formulations, offering RESOMER Zero and RESOMER Sterile versions of its standard andSelect customized solutions.  “These additions to our portfolio provide pharmaceutical companies with greater flexibility for their products – while delivering the same high quality, excellent safety profiles, and security of supply they have come to expect from the RESOMER brand,” said, Dr. Thomas Rierme...